[1] Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte[J]. Physiol Rev, 2003,83(1):253-307.[2] Susztak K, Raff A C, Schiffer M, et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy[J]. Diabetes, 2006,55(1):225-233.[3] 刘志红.足细胞是肾小球损伤的中心环节.健康报,2012-10-17(8).[4] 中华医学会糖尿病分会.中国2型糖尿病防治指南(2010年版).北京:中国糖尿病杂志,2012.[5] Huang L, You Y S, Wu W. Role of CD2-associated protein in podocyte apoptosis and proteinuria induced by angiotensin Ⅱ[J]. Ren Fail, 2014,36(8):1328-1332.[6] Ha T S, Hong E J, Han G D. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signaling[J]. Diabetes Metab Res Re, 2015,3(1):50-60.[7] 赵非,黄松明,张爱华,等.CD2AP、F-actin在肾病大鼠中的表达及意义[J].中国病理生理杂志,2006,22(1):182-186.[8] Benzing T. Signaling at the slit diaphragm[J]. JASN,2004,15(6):1328-1391.[9] Benoit G, Machuca E, Nevo F, et al. Analysis of recessive CD2AP and ACTN4 mutations in steroid-resistant nephrotic syn-drome[J]. Pediatr Nephrol, 2010,25(3):445-451.[10] 孟大川,余自华,王道静,等.中国汉族儿童散发性激素耐药型肾病综合征CD2AP基因突变分析[J].临床儿科杂志,2012,30(7):641-645.[11] Gigante M, Pontrelli P, Montemurno E, et al. CD2AP mutations are associated with sporadic nephritic syndrome and focal segmental glomerulosclerosis[J]. Nephrol Dial Transplant, 2009,24(6):1858-1864.[12] 李俊美.吕仁和教授治疗糖尿病肾病的经验[J].四川中医,2009,27(5):1-3.[13] 赵迪.高彦彬教授治疗糖尿病肾病学术思想和经验[J].中医研究,2007,20(1):42-44.[14] 张颖.黄芪注射液联合缬沙坦治疗糖尿病肾病的效果观察[J].解放军医药杂志,2012,24(8):52-54.[15] 奚悦,李敬林.益气活络方对早期2型糖尿病肾病患者的临床疗效[J].中国医科大学学报,2013,42(6):485-488.[16] 艾志敏.芪卫颗粒干预糖尿病肾病临床和部分作用机制研究.北京:北京中医药大学,2013.[17] 李敏州,高彦彬,马鸣飞,等.芪卫颗粒对KK-Ay小鼠肾组织TGF-β_1/Smads信号转导通路的影响[J].中医杂志,2013,54(13):1141-1144.[18] 周静鑫. 芪卫颗粒干预糖尿病肾病临床疗效及其保护足细胞作用机制研究[M].北京:北京中医药大学,2014.[19] 李步满,高彦彬,吴丽丽,等.中药芪卫颗粒对2型糖尿病大鼠肾脏氧化应激及病理改变的影响[J].中国中西医结合肾病杂志,2011,12(1):20-23. |